- Home
- Publications
- Publication Search
- Publication Details
Title
PDE5 Inhibitors Enhance Celecoxib Killing in Multiple Tumor Types
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR PHYSIOLOGY
Volume 230, Issue 5, Pages 1115-1127
Publisher
Wiley
Online
2014-10-10
DOI
10.1002/jcp.24843
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PDE5 inhibitors enhance the lethality of standard of care chemotherapy in pediatric CNS tumor cells
- (2014) Jane L Roberts et al. CANCER BIOLOGY & THERAPY
- The discovery and development of cyclooxygenase-2 inhibitors as potential anticancer therapies
- (2014) Mohsen Vosooghi et al. Expert Opinion on Drug Discovery
- Nitric oxide inhibits autophagy via suppression of JNK in meniscal cells
- (2014) C. Shen et al. RHEUMATOLOGY
- Dolastatin, along with Celecoxib, stimulates apoptosis by a mechanism involving oxidative stress, membrane potential change and PI3-K/AKT pathway down regulation
- (2013) Honit Piplani et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Histone deacetylase inhibitors restore toxic BH3 domain protein expression in anoikis-resistant mammary and brain cancer stem cells, thereby enhancing the response to anti-ERBB1/ERBB2 therapy
- (2013) Nichola Cruickshanks et al. CANCER BIOLOGY & THERAPY
- Enhanced apoptotic effects by downregulating Mcl-1: Evidence for the improvement of photodynamic therapy with Celecoxib
- (2013) Jiaxing Song et al. EXPERIMENTAL CELL RESEARCH
- An update on pharmacological treatment of erectile dysfunction with phosphodiesterase type 5 inhibitors
- (2013) Roberto Bruzziches et al. EXPERT OPINION ON PHARMACOTHERAPY
- Inhibition of autophagy and glycolysis by nitric oxide during hypoxia–reoxygenation impairs cellular bioenergetics and promotes cell death in primary neurons
- (2013) Gloria A. Benavides et al. FREE RADICAL BIOLOGY AND MEDICINE
- Sorafenib and HDAC inhibitors synergize with TRAIL to kill tumor cells
- (2013) Hossein A. Hamed et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Induction but not inhibition of COX-2 confers human lung cancer cell apoptosis by celecoxib
- (2013) Robert Ramer et al. JOURNAL OF LIPID RESEARCH
- P2X7 receptor-induced death of motor neurons by a peroxynitrite/FAS-dependent pathway
- (2013) Mandi Gandelman et al. JOURNAL OF NEUROCHEMISTRY
- C22:0- and C24:0-dihydroceramides Confer Mixed Cytotoxicity in T-Cell Acute Lymphoblastic Leukemia Cell Lines
- (2013) Michael W. Holliday Jr. et al. PLoS One
- Celecoxib-Induced Cytotoxic Effect Is Potentiated by Inhibition of Autophagy in Human Urothelial Carcinoma Cells
- (2013) Kuo-How Huang et al. PLoS One
- Reactive nitrogen species regulate autophagy through ATM-AMPK-TSC2-mediated suppression of mTORC1
- (2013) D. N. Tripathi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting Hepatoma Using Nitric Oxide Donor Strategies
- (2012) Raúl González et al. ANTIOXIDANTS & REDOX SIGNALING
- Inhibition of Sphingolipid Metabolism Enhances Resveratrol Chemotherapy in Human Gastric Cancer Cells
- (2012) Kyong-Oh Shin et al. Biomolecules & Therapeutics
- OSU-03012 suppresses GRP78/BiP expression that causes PERK-dependent increases in tumor cell killing
- (2012) Laurence Booth et al. CANCER BIOLOGY & THERAPY
- Nitric oxide (•NO) generation but not ROS plays a major role in silibinin-induced autophagic and apoptotic death in human epidermoid carcinoma A431 cells
- (2012) Yang Yu et al. FREE RADICAL RESEARCH
- Chemoprevention in familial adenomatous polyposis
- (2011) Brian Kim et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Lung Cancer Chemoprevention with Celecoxib in Former Smokers
- (2011) Jenny T. Mao et al. Cancer Prevention Research
- Celecoxib Promotes c-FLIP Degradation through Akt-Independent Inhibition of GSK3
- (2011) S. Chen et al. CANCER RESEARCH
- Nitric Oxide and Cyclic GMP Signaling Pathway as a Focus for Drug Development
- (2011) A.Y. Kots et al. CURRENT MEDICINAL CHEMISTRY
- Activation of ceramide synthase 6 by celecoxib leads to a selective induction of C16:0-ceramide
- (2010) Susanne Schiffmann et al. BIOCHEMICAL PHARMACOLOGY
- Vorinostat and Sorafenib Increase CD95 Activation in Gastrointestinal Tumor Cells through a Ca2+-De novo Ceramide-PP2A-Reactive Oxygen Species-Dependent Signaling Pathway
- (2010) M. A. Park et al. CANCER RESEARCH
- ERK/Ribosomal S6 Kinase (RSK) Signaling Positively Regulates Death Receptor 5 Expression through Co-activation of CHOP and Elk1
- (2010) You-Take Oh et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action
- (2010) S. H. Francis et al. PHARMACOLOGICAL REVIEWS
- Sildenafil increases chemotherapeutic efficacy of doxorubicin in prostate cancer and ameliorates cardiac dysfunction
- (2010) A. Das et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Celecoxib prevents tumor growth in an animal model by a COX-2 independent mechanism
- (2009) Amanda Leite Bastos-Pereira et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Cytotoxic effects of celecoxib on Raji lymphoma cells correlate with aggravated endoplasmic reticulum stress but not with inhibition of cyclooxygenase-2
- (2009) Szu-Ting Chen et al. LEUKEMIA RESEARCH
- The anti-proliferative potency of celecoxib is not a class effect of coxibs
- (2008) Susanne Schiffmann et al. BIOCHEMICAL PHARMACOLOGY
- Aggravated Endoplasmic Reticulum Stress as a Basis for Enhanced Glioblastoma Cell Killing by Bortezomib in Combination with Celecoxib or Its Non-Coxib Analogue, 2,5-Dimethyl-Celecoxib
- (2008) A. Kardosh et al. CANCER RESEARCH
- Selective COX2 inhibition improves whole body and muscular insulin resistance in fructose-fed rats
- (2008) P.-S. Hsieh et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Protein Kinase G-dependent Cardioprotective Mechanism of Phosphodiesterase-5 Inhibition Involves Phosphorylation of ERK and GSK3β
- (2008) Anindita Das et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- COX-2 inhibition is neither necessary nor sufficient for celecoxib to suppress tumor cell proliferation and focus formation in vitro
- (2008) Huan-Ching Chuang et al. Molecular Cancer
- N-(4-Hydroxyphenyl)retinamide increases dihydroceramide and synergizes with dimethylsphingosine to enhance cancer cell killing
- (2008) H. Wang et al. MOLECULAR CANCER THERAPEUTICS
- OSU-03012 Stimulates PKR-Like Endoplasmic Reticulum-Dependent Increases in 70-kDa Heat Shock Protein Expression, Attenuating Its Lethal Actions in Transformed Cells
- (2008) M. A. Park et al. MOLECULAR PHARMACOLOGY
- Celecoxib-induced growth inhibition in SW480 colon cancer cells is associated with activation of protein kinase G
- (2007) Jae-Won Soh et al. MOLECULAR CARCINOGENESIS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started